SNSE/CVS (SNSE/CVS)

Santiago Stock Exchange: SNSE/CVS · USD

$92.5

-0.15 (-0.2%)· Recorded snapshot

Market cap	114.9T
Revenue (ttm)	380.2T
Net income (ttm)	4.5T
EPS (ttm)	$3,763
P/E (trailing)	24.2x
P/E (forward)	11.1x
Dividend	$2,465 (2.70%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 380.2T
Net income (ttm): 4.5T
EPS (ttm): $3,763
P/E (trailing): 24.2x
P/E (forward): 11.1x
Market cap: 114.9T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E11.1

P25 n/aP50 n/aP75 n/a

Trailing P/E24.2

P25 n/aP50 n/aP75 n/a

ROE6.2

P25 n/aP50 n/aP75 n/a

ROIC7.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SNSE/CVS indicators

Market & fundamental data

Available fields

243

Groups with data

Currency

USD

Showing 243 of 243 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CLP
Country	United States
Country code	CL
Earnings date	2026-11-04
Employees	259,500
Employees change	0
Employees growth	0%
Enterprise value	$176.4T
Exchange	Santiago Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1963
Industry	Healthcare Plans
Is primary listing	No
ISIN number	US1266501006
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Market cap	$114.9T
Next earnings date	2026-11-04
Price	$92.53
Price currency	USD
Sector	Healthcare
SIC code	8000
Stock price date	2026-10-27
Symbol	snse/CVS
Website	https://www.cvshealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	23.26x
Average P/E ratio (3Y)	35.75x
Average P/E ratio (5Y)	30.59x
Earnings yield	4.12%
EV/Earnings	39.04x
EV/EBIT	14.73x
EV/EBITDA	9.09x
EV/FCF	16.24x
EV/Sales	0.43x
FCF / EV yield	6.16%
FCF yield	9.46%
Forward P/E	11.12x
Graham number	69.82685
Graham upside	-24.54%
Lynch fair value	$18.21
Lynch upside	-80.32%
P/(FCF - SBC) ratio	11.25x
P/(OCF - SBC) ratio	8.83x
P/B ratio	1.56x
P/E ratio	24.24x
P/FCF ratio	10.57x
P/OCF ratio	8.41x
P/S ratio	0.3x
Price/EBITDA ratio	7.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	2.95%
EBITDA margin	4.04%
Effective tax rate	15.59%
FCF margin	2.66%
Gross margin	13.64%
Operating margin	2.95%
Pretax margin	1.4%
Profit margin	1.19%
Profit per employee	$17.4M
Profitable quarters	3
Profitable years	7
Revenue per employee	$1.5B
ROA	2.97%
ROA (5Y)	3.25%
ROCE	7.29%
ROE	6.21%
ROE (5Y)	7.3%
ROIC	7.17%
ROIC (5Y)	6.76%
SBC / revenue	0.17%
Tax / revenue	0.22%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	6.3%
EPS growth (Q)	188.75%
EPS growth (QoQ)	0.43%
EPS growth 10Y	-1.29%
EPS growth 3Y	18.83%
EPS growth 5Y	-6.92%
EPS growth quarters	3
EPS growth years	0
FCF growth	145.98%
FCF growth (Q)	338.3%
FCF growth (QoQ)	66.29%
FCF growth 3Y	-12.7%
FCF growth 5Y	0.24%
Gross profit growth	10.11%
Gross profit growth (Q)	15.28%
Gross profit growth 3Y	1.97%
Gross profit growth 5Y	3.1%
Net income growth	7.92%
Net income growth (Q)	191.77%
Net income growth (QoQ)	1.22%
Net income growth 3Y	18.15%
Net income growth 5Y	-7.45%
Net income growth quarters	3
Net income growth years	0
OCF growth	95.3%
OCF growth (Q)	234.48%
OCF growth (QoQ)	49.33%
OCF growth 10Y	4.54%
OCF growth 3Y	-10.36%
OCF growth 5Y	0.83%
Operating income growth	30.17%
Operating income growth (Q)	47.59%
Operating income growth 3Y	-5.64%
Operating income growth 5Y	-1.43%
Revenue growth	7.37%
Revenue growth (Q)	7.14%
Revenue growth (QoQ)	5.61%
Revenue growth 10Y	9.49%
Revenue growth 3Y	6.87%
Revenue growth 5Y	8.28%
Revenue growth quarters	53
Revenue growth years	15

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-2.8T
Depreciation and amortization	$4.5T
EBIT	$11.2T
EBITDA	$15.4T
EPS	$3,763.18
Financing cash flow	$-7.8T
Free cash flow	$10.8T
Free cash flow minus SBC	$10.2T
Gross profit	$51.9T
Income taxes	$831B
Investing cash flow	$-6.3T
Net borrowing	$-5.2T
Net cash flow	$-449.6B
Net income	$4.5T
Operating cash flow minus SBC	$13T
Operating income	$11.2T
Revenue	$380.2T
Stock-based compensation	$658.7B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.43
Book value per share	$57,456.54
Debt / EBITDA	3.87
Debt / equity	0.96
Debt / FCF	6.49
Goodwill	$84.3T
Interest coverage	3.92
Long-term assets	$159.5T
Long-term liabilities	$74.4T
Net cash (debt)	$-57.4T
Net cash / market cap	-50.18%
Net debt / EBITDA	3.74
Net debt / equity	0.78
Net debt / FCF	5.3
Piotroski F-Score	7
Property, plant and equipment	$27.2T
Shareholders' equity	$73.6T
Tangible book value	$-28T
Tangible book value per share	$-21,929.53
Total assets	$233.8T
Total cash	$12.9T
Total debt	$70.3T
Total liabilities	$160.2T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.61
Current assets	$74.3T
Current liabilities	$85.8T
Current ratio	0.87
Inventory turnover	20.32
Net working capital	$-20.1T
Quick ratio	0.62
Working capital	$-10.8T
Working capital turnover	-25,170.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.19%
Dividend growth	0%
Dividend growth (10Y)	4.58%
Dividend growth (3Y)	3.2%
Dividend growth (5Y)	5.87%
Dividend growth years	0
Dividend payment date	2026-11-02
Dividend payment years	14
Dividend payout frequency	Quarterly
Dividend per share	$2,464.79
Dividend yield	2.7%
Ex-dividend date	2026-10-22
Last dividend	$0.67
Payout ratio	69.86%
Shareholder yield	1.51%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	7.52%
10Y return CAGR	3.89%
10Y total return	46.41%
150-day SMA	$86.26
1D price change	-0.16%
1M price change	5.63%
1M total return	6.39%
1W price change	5.69%
1W total return	6.45%
1Y price change	24.64%
1Y return CAGR	28.5%
1Y total return	28.48%
20-day SMA	$89.02
200-day SMA	$84.35
3M price change	-14.01%
3M total return	-13.39%
3Y price change	32.87%
3Y return CAGR	14.15%
3Y total return	48.75%
50-day SMA	$91.73
50-day SMA vs 200-day SMA	50over200
52-week high	$107.61
52-week high date	2026-07-27
52-week low	$74.24
52-week low date	2025-12-24
5Y price change	10.68%
5Y return CAGR	5.52%
5Y total return	30.83%
6M price change	17.68%
6M total return	19.27%
All-time high	$107.68
All-time high date	2022-01-27
All-time low	$43.74
All-time low date	2024-12-23
Average true range (ATR)	$0.46
Average volume	0
Change from 52-week high	-14.01%
Change from 52-week low	24.64%
Change from all-time high	-14.07%
Change from all-time low	111.55%
Monthly RSI	61.82
Previous close	$92.68
Price vs 150-day SMA	7.27%
Price vs 20-day SMA	3.94%
Price vs 200-day SMA	9.7%
Price vs 50-day SMA	0.88%
Relative volume	20
RSI	66.62
Sharpe ratio	0.72
Sharpe ratio (3Y)	0.44
Sharpe ratio (5Y)	0.21
Sortino ratio	2.57
Sortino ratio (3Y)	0.93
Sortino ratio (5Y)	0.51
Weekly RSI	58.05
YTD price change	17.68%
YTD total return	21.31%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.3B
Shares change (QoQ)	0.63%
Shares change (YoY)	1.19%
Shares held by insiders	0.09%
Shares held by institutions	90.42%
Short ratio	2 days

Deeper analysis on SNSE/CVS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SNSE/CVS report

Is a complete SNSE/CVS research report available?

No complete published report is available for snse/CVS (SNSE/CVS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SNSE/CVS (SNSE/CVS)

Price

Financial snapshot

Fair-value bridge

Latest news · SNSE/CVS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SNSE/CVS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SNSE/CVS

Frequently asked questions